Diseases, Conditions, Syndromes

Team develops new broadly protective vaccines for H3N2 influenza

A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine ...

Diseases, Conditions, Syndromes

Influenza viruses can hide from the immune system

Influenza is able to mask itself, so that the virus is not initially detected by our immune system. This is the result of new research from Aarhus University. The researchers behind the study hope that the discovery can be ...

Diseases, Conditions, Syndromes

Human antibody reveals hidden vulnerability in influenza virus

The ever-changing "head" of an influenza virus protein has an unexpected Achilles heel, report scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. ...

Diseases, Conditions, Syndromes

Disparities in influenza outcomes

Influenza infections kill between 3,000 and 49,000 people each year in the United States. Understanding risk factors for severe influenza outcomes, such as hospitalization, can help guide vaccination programs and reduce disease ...

Diseases, Conditions, Syndromes

The search for a universal influenza vaccine

No one wants to catch the flu, and the best line of defense is the seasonal influenza vaccine. But producing an effective annual flu shot relies on accurately predicting which flu strains are most likely to infect the population ...

Diseases, Conditions, Syndromes

UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza

Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza ...

page 8 from 23